Schizophrenia Clinical Trials in Phoenix

Showing 141-160 of 167 trials

CAFE Comparison of Atypicals in First Episode of Psychosis

NCT00034892

The purpose of this study is to compare the effectiveness, tolerability, and efficacy of the currently available atypical antipsychotic drugs olanzapine (2.5-20 mg/day), quetiapine (100-800 mg/day) and risperidone (0.5-4 mg/day) in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder who are experiencing their first psychotic episode.

SchizophreniaPsychotic DisordersMental Health+1 more

AstraZenecaStarted Mar 2002

Stanford, California, United States • Miami, Florida, United States • Atlanta, Georgia, United States +23 more locations

COMPLETEDPhase 2256 miles

Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia

NCT00528905

The purpose of this study is to demonstrate that AZD3480 improves cognition in patients with stable schizophrenia who are being treated with an atypical antipsychotic and who are active cigarette smokers, to assess the safety and tolerability of AZD3480 and to define the optimal dose(s) to be used in future trials.

Schizophrenia

AstraZeneca400 participantsStarted Aug 2007

Little Rock, Arkansas, United States • Anaheim, California, United States • Cerritos, California, United States +77 more locations

CAFE Comparison of Atypicals in First Episode of Psychosis

Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia

Schizophrenia Trials in Other Cities

Study Comparing Bifeprunox to Risperidone in Treatment of Outpatients With Schizophrenia With Weight as Primary Endpoint

A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents

A Long-Term, Open-Label, Study on Schizophrenia

Study to Evaluate the Efficacy and Safety of Armodafinil as Adjunctive Therapy in Adults With Schizophrenia

Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia

Effect Of Talnetant Versus Risperidone Versus Placebo On Psychotic Symptoms In Schizophrenic Patients

Immediate Release (IR) to Sustained Release (SR) Switching Study: Study of Switching From IR Seroquel to SR Seroquel in Outpatients With Schizophrenia

Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects

28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Years

Efficacy & Safety of Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill Patients With Schizophrenia

Large Simple Trial (LST) Of Cardiovascular Safety Of Ziprasidone And Olanzapine- (Zodiac)

Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia

The Use of Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (The METS Study)

To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia

Dose-response Study to Evaluate Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo in Acute Exacerbation of Schizophrenia

Effects of Cariprazine on Cardiac Repolarization in Patients With Schizophrenia

Effect of Calories and Fat Content on the Pharmacokinetics of Lurasidone HCl

A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children

Other Conditions in Phoenix